10x Genomics Inc (TXG)
14.14
-0.78
(-5.26%)
USD |
NASDAQ |
Nov 14, 16:00
14.11
-0.02
(-0.18%)
After-Hours: 20:00
10x Genomics Profit Margin (Quarterly): -23.58% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -23.58% |
| June 30, 2024 | -24.75% |
| March 31, 2024 | -42.52% |
| December 31, 2023 | -26.61% |
| September 30, 2023 | -60.52% |
| June 30, 2023 | -42.51% |
| March 31, 2023 | -37.79% |
| December 31, 2022 | -11.02% |
| September 30, 2022 | -31.98% |
| June 30, 2022 | -56.24% |
| March 31, 2022 | -37.04% |
| December 31, 2021 | -12.85% |
| September 30, 2021 | -13.70% |
| Date | Value |
|---|---|
| June 30, 2021 | -9.54% |
| March 31, 2021 | -10.92% |
| December 31, 2020 | -370.3% |
| September 30, 2020 | -91.69% |
| June 30, 2020 | -93.62% |
| March 31, 2020 | -29.40% |
| December 31, 2019 | -9.48% |
| September 30, 2019 | -15.69% |
| June 30, 2019 | -19.49% |
| March 31, 2019 | -6.79% |
| December 31, 2018 | -149.4% |
| September 30, 2018 | -41.92% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-370.3%
Minimum
Dec 2020
-9.48%
Maximum
Dec 2019
-51.80%
Average
-30.69%
Median
Profit Margin (Quarterly) Benchmarks
| Omnicell Inc | 3.06% |
| American Shared Hospital Services | 51.05% |
| Astrana Health Inc | 3.36% |
| Cryo-Cell International Inc | 13.04% |
| P3 Health Partners Inc | -3.17% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -24.99% |
| Return on Assets | -19.40% |
| Return on Invested Capital | -24.99% |
| Gross Profit Margin (Quarterly) | 70.16% |
| Operating Margin (Quarterly) | -27.36% |
| Return on Net Operating Assets | -33.95% |